448 related articles for article (PubMed ID: 26951383)
1. Decrease of VEGF-A in myeloid cells attenuates glioma progression and prolongs survival in an experimental glioma model.
Osterberg N; Ferrara N; Vacher J; Gaedicke S; Niedermann G; Weyerbrock A; Doostkam S; Schaefer HE; Plate KH; Machein MR
Neuro Oncol; 2016 Jul; 18(7):939-49. PubMed ID: 26951383
[TBL] [Abstract][Full Text] [Related]
2. Resident microglia rather than peripheral macrophages promote vascularization in brain tumors and are source of alternative pro-angiogenic factors.
Brandenburg S; Müller A; Turkowski K; Radev YT; Rot S; Schmidt C; Bungert AD; Acker G; Schorr A; Hippe A; Miller K; Heppner FL; Homey B; Vajkoczy P
Acta Neuropathol; 2016 Mar; 131(3):365-78. PubMed ID: 26718201
[TBL] [Abstract][Full Text] [Related]
3. Flt-1 signaling in macrophages promotes glioma growth in vivo.
Kerber M; Reiss Y; Wickersheim A; Jugold M; Kiessling F; Heil M; Tchaikovski V; Waltenberger J; Shibuya M; Plate KH; Machein MR
Cancer Res; 2008 Sep; 68(18):7342-51. PubMed ID: 18794121
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of CYP4A by a novel flavonoid FLA-16 prolongs survival and normalizes tumor vasculature in glioma.
Wang C; Li Y; Chen H; Zhang J; Zhang J; Qin T; Duan C; Chen X; Liu Y; Zhou X; Yang J
Cancer Lett; 2017 Aug; 402():131-141. PubMed ID: 28602979
[TBL] [Abstract][Full Text] [Related]
5. Endothelial-like malignant glioma cells in dynamic three dimensional culture identifies a role for VEGF and FGFR in a tumor-derived angiogenic response.
Smith SJ; Ward JH; Tan C; Grundy RG; Rahman R
Oncotarget; 2015 Sep; 6(26):22191-205. PubMed ID: 26203665
[TBL] [Abstract][Full Text] [Related]
6. Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response.
Sielska M; Przanowski P; Wylot B; Gabrusiewicz K; Maleszewska M; Kijewska M; Zawadzka M; Kucharska J; Vinnakota K; Kettenmann H; Kotulska K; Grajkowska W; Kaminska B
J Pathol; 2013 Jul; 230(3):310-21. PubMed ID: 23520016
[TBL] [Abstract][Full Text] [Related]
7. Combined targeting of interleukin-6 and vascular endothelial growth factor potently inhibits glioma growth and invasiveness.
Saidi A; Hagedorn M; Allain N; Verpelli C; Sala C; Bello L; Bikfalvi A; Javerzat S
Int J Cancer; 2009 Sep; 125(5):1054-64. PubMed ID: 19431143
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis in malignant gliomas.
Plate KH; Risau W
Glia; 1995 Nov; 15(3):339-47. PubMed ID: 8586468
[TBL] [Abstract][Full Text] [Related]
9. Glioma-derived galectin-1 regulates innate and adaptive antitumor immunity.
Verschuere T; Toelen J; Maes W; Poirier F; Boon L; Tousseyn T; Mathivet T; Gerhardt H; Mathieu V; Kiss R; Lefranc F; Van Gool SW; De Vleeschouwer S
Int J Cancer; 2014 Feb; 134(4):873-84. PubMed ID: 23929302
[TBL] [Abstract][Full Text] [Related]
10. VEGF as a modulator of the innate immune response in glioblastoma.
Turkowski K; Brandenburg S; Mueller A; Kremenetskaia I; Bungert AD; Blank A; Felsenstein M; Vajkoczy P
Glia; 2018 Jan; 66(1):161-174. PubMed ID: 28948650
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sites.
Guo P; Xu L; Pan S; Brekken RA; Yang ST; Whitaker GB; Nagane M; Thorpe PE; Rosenbaum JS; Su Huang HJ; Cavenee WK; Cheng SY
Cancer Res; 2001 Dec; 61(23):8569-77. PubMed ID: 11731444
[TBL] [Abstract][Full Text] [Related]
12. The anti-angiogenic role of soluble-form VEGF receptor in malignant gliomas.
Takano S; Ishikawa E; Matsuda M; Sakamoto N; Akutsu H; Yamamoto T; Matsumura A
Int J Oncol; 2017 Feb; 50(2):515-524. PubMed ID: 28000842
[TBL] [Abstract][Full Text] [Related]
13. Deletion of vascular endothelial growth factor in myeloid cells accelerates tumorigenesis.
Stockmann C; Doedens A; Weidemann A; Zhang N; Takeda N; Greenberg JI; Cheresh DA; Johnson RS
Nature; 2008 Dec; 456(7223):814-8. PubMed ID: 18997773
[TBL] [Abstract][Full Text] [Related]
14. Minor contribution of bone marrow-derived endothelial progenitors to the vascularization of murine gliomas.
Machein MR; Renninger S; de Lima-Hahn E; Plate KH
Brain Pathol; 2003 Oct; 13(4):582-97. PubMed ID: 14655762
[TBL] [Abstract][Full Text] [Related]
15. Loss of SOCS3 in myeloid cells prolongs survival in a syngeneic model of glioma.
McFarland BC; Marks MP; Rowse AL; Fehling SC; Gerigk M; Qin H; Benveniste EN
Oncotarget; 2016 Apr; 7(15):20621-35. PubMed ID: 26967393
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of anti-tumor activity by low-dose combination of the recombinant urokinase kringle domain and celecoxib in a glioma model.
Kim CK; Joe YA; Lee SK; Kim EK; O E; Kim HK; Oh BJ; Hong SH; Hong YK
Cancer Lett; 2010 Feb; 288(2):251-60. PubMed ID: 19664879
[TBL] [Abstract][Full Text] [Related]
17. Glioma stem cells-derived exosomes promote the angiogenic ability of endothelial cells through miR-21/VEGF signal.
Sun X; Ma X; Wang J; Zhao Y; Wang Y; Bihl JC; Chen Y; Jiang C
Oncotarget; 2017 May; 8(22):36137-36148. PubMed ID: 28410224
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of miR-107 Inhibits Glioma Angiogenesis and VEGF Expression.
Chen L; Li ZY; Xu SY; Zhang XJ; Zhang Y; Luo K; Li WP
Cell Mol Neurobiol; 2016 Jan; 36(1):113-20. PubMed ID: 26084601
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor-driven glioma growth and vascularization in an orthotopic rat model monitored by magnetic resonance imaging.
Goldbrunner RH; Bendszus M; Sasaki M; Kraemer T; Plate KH; Roosen K; Tonn JC
Neurosurgery; 2000 Oct; 47(4):921-9; discussion 929-30. PubMed ID: 11014432
[TBL] [Abstract][Full Text] [Related]
20. Podoplanin increases migration and angiogenesis in malignant glioma.
Grau SJ; Trillsch F; Tonn JC; Goldbrunner RH; Noessner E; Nelson PJ; von Luettichau I
Int J Clin Exp Pathol; 2015; 8(7):8663-70. PubMed ID: 26339454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
